Alliance for Cancer Gene Therapy announced the availability of grants up to $500,000 each for the 2019 grant cycle to fund investigators in the field of cancer gene therapy. The focus for the grants this year are scientists centering their work on solid, metastatic and childhood cancers. ACGT is known for its 18-year history of... […]
The 2019 Szent-Györgyi Prize for Progress in Cancer Research will be awarded to Steven A. Rosenberg of the NCI Center for Cancer Research.
Cell biologist Ron Vale was elected the executive director of the Howard Hughes Medical Institute's Janelia Research Campus and an HHMI vice president. His appointment will begin in early 2020.
Baylor College of Medicine has consolidated its NCI-designated Dan L Duncan Comprehensive Cancer Center clinics and services into one location on its new McNair Campus in Houston.
Merck and Immune Design announced the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Immune Design for $5.85 per share in cash for an approximate value of $300 million.
Suzanne Doubrava will be joining the Division of Psychiatry within the Department of Medicine at Fox Chase Cancer Center.
Caryn Lerman was named director of USC Norris Comprehensive Cancer Center.
NCI would like you to know that it has a pot of money for commercialization projects—please apply.
The European Commission has approved Sprycel (dasatinib) in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
FDA has accepted a new supplemental Biologics License Application for Keytruda as monotherapy or in combination with platinum and 5-fluorouracil chemotherapy for the first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma.
